We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cancer Biomarkers: Powering Precision Medicine

Article   Jan 31, 2020 | By Alison Halliday, Ph.D.

 
Cancer Biomarkers: Powering Precision Medicine
 
 
Advertisement
 

RELATED ARTICLES

One Step Closer to CRISPR-Cas9 Cancer Therapies

Article

Although not fully deterministic for the development of cancer, certain genes – such as the BRCA1 gene, are well known to be implicated and to significantly raise a person’s cancer risk. Why is it then, that we have not heard more about CRISPR-Cas9 being developed for cancer therapies?

READ MORE

Talking Vitamin D and COVID-19 With Professor Adrian Martineau

Article

Professor Adrian Martineau at Queen Mary University of London is the lead researcher on the CORONAVIT trial that is exploring the effectiveness of correcting vitamin D deficiency in reducing the risk of developing COVID-19. In this interview, we ask Martineau about the rationale behind this study, what impact the UK COVID-19 vaccine rollout may have on the power of the trial and the potential impact of the results.

READ MORE

Cell Culture Contamination: Mycoplasma and Problematic Cell Lines Continue To Cause Concern

Article

Cell culture contamination is a major concern for biological and biomedical research, as well as for biologics therapeutics production. Here, we take a closer look at mycoplasma contamination and problematic cell lines.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE